AMPK activation coupling SENP1-Sirt3 axis protects against acute kidney injury

Minyan Zhu1, Jianli He2, Yao Xu1

  • 1Department of Nephrology, Molecular Cell Lab for Kidney Disease, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 201207, China.

Insights

Targeting the SENP1-Sirt3 pathway protects against acute kidney injury (AKI) and subsequent fibrosis. Activating this axis reduces mitochondrial damage and inflammation, offering a potential therapeutic strategy for kidney disease.

Area of Science:

  • Nephrology
  • Mitochondrial Biology
  • Molecular Signaling

Background:

  • Acute kidney injury (AKI) is a significant clinical issue leading to kidney fibrosis with limited treatments.
  • Mitochondrial dysfunction in proximal tubular epithelial cells (PTECs) plays a crucial role in AKI pathogenesis.
  • The SENP1-Sirt3 signaling pathway's role in AKI requires further investigation.

Purpose of the Study:

  • To investigate the role of the SENP1-Sirt3 signaling pathway in AKI.
  • To explore the correlation between this pathway and mitochondrial dysfunction in PTECs.
  • To identify potential therapeutic targets for AKI-induced kidney fibrosis.

Main Methods:

  • Utilized folic acid (FA) and ischemia-reperfusion-induced (IRI) AKI mouse models.
  • Investigated Sirt3 SUMOylation site mutation (Sirt3 KR) and pharmacological stimulation (metformin, NAC, MitoQ).
  • Performed metabolomics analysis and assessed mitochondrial function, oxidative stress, and apoptosis markers.

Main Results:

  • Sirt3 KR mutation or metformin treatment protected against AKI, inflammation, and fibrosis.
  • These interventions reduced mitochondrial acetylation of SOD2, decreased mitochondrial reactive oxygen species (mtROS), and restored ATP levels.
  • Metformin activated the AMPK pathway, promoting the SENP1-Sirt3 axis and protecting PTECs.

Conclusions:

  • Augmented mitochondrial deSUMOylation of Sirt3, via the AMPK pathway, protects against AKI.
  • The Sirt3-SOD2-mtROS axis is a key mediator in mitigating renal inflammation and fibrosis.
  • Targeting the SENP1-Sirt3 pathway presents a promising therapeutic strategy for AKI.

Related Concept Videos

Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
28
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
34
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.7K
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
28
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.4K
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
25